Current Report Filing (8-k)
September 14 2018 - 5:44PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): September 10, 2018
PCM,
Inc.
(Exact
Name of Registrant as Specified in its Charter)
Delaware
|
000-25790
|
95-4518700
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
1940
E. Mariposa Avenue
El
Segundo, California 90245
(Address
of Principal Executive Offices)
Registrant’s
telephone number, including area code:
(310) 354-5600
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
[ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
[ ]
Item
1.01. Entry into a Material Definitive Agreement.
On
September 10, 2018, the Board of Directors (the “Board”) of PCM, Inc. (the “Company”) approved a new form
of Indemnification Agreement (the “Amended and Restated Indemnification Agreement”) to be entered into with the Company’s
officers and directors. Pursuant to the Amended and Restated Indemnification Agreements, the Company agrees to indemnify and advance
expenses and costs incurred by each indemnitee in connection with any threatened, pending or completed action, suit, proceeding,
or alternative dispute resolution mechanism arising as a result of his or her service as a director or officer, to the fullest
extent permitted by the laws of the State of Delaware. Among other things, the revisions to the form clarify the scope of the
Company’s indemnification obligations and clarify the scope of the indemnified party’s rights. The Amended and Restated
Indemnification Agreements also establish various related procedures, processes and requirements.
The
foregoing description of the form of Amended and Restated Indemnification Agreement does not purport to be complete and is qualified
in its entirety by reference to the form of Amended and Restated Indemnification Agreement filed herewith as Exhibit 10.1, which
is incorporated herein by reference.
Item
5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On
September 10, 2018, the Board approved amendments to the Company’s Amended and Restated Bylaws (the “Bylaws”)
to make revisions to Article IX of the Bylaws, which provides for indemnification of officers, directors and certain agents. The
amendments generally include (i) a narrowed class of individuals required to be indemnified by the Company, (ii) clarifications
on rights to advancement of expenses of former officers and directors, and (iii) clarifications on certain procedures and
presumptions with respect to the enforcement of indemnification rights. The amendments to the Bylaws were effective upon approval
by the Board. As permitted under Bylaws, the Company has purchased directors’ and officers’ insurance to support the
Company’s indemnification obligations.
The
foregoing description of the does not purport to be complete and is qualified in its entirety by reference to the complete text
of the Second Amended and Restated Bylaws, along with a copy marked to show changes from the prior Bylaws, filed herewith as Exhibits
3.1 and 3.2, which are incorporated herein by reference.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
September 14, 2018
|
PCM, INC.
|
|
|
|
|
By:
|
/s/
Brandon H. LaVerne
|
|
Name:
|
Brandon H. LaVerne
|
|
Title:
|
Chief Financial Officer
|
PCM (NASDAQ:PCMI)
Historical Stock Chart
From Aug 2024 to Sep 2024
PCM (NASDAQ:PCMI)
Historical Stock Chart
From Sep 2023 to Sep 2024